Top Stories for the Week of March 12th 2007

Monday, March 12, 2007 11:55 AM

Top News

eClinical Industry Strong in 2006

Slowed for years by the clinical trials industry's sluggish adoption rates and frustrations about technological integration in an overcrowded marketplace, most companies offering clinical trial software and technology reported banner revenues for 2006 and the signs remain positive in the first quarter of 2007.

INC Research Opens New Switzerland Office,India and Latin America Next

Raleigh, N.C.-based INC Research, contract research organization (CRO), has opened a new office in Zürich, Switzerland. And because of the increasing demand to outsource clinical trials in emerging regions, INC will be opening up new offices in India and Latin America before the end of the year.

Other breaking news...

  • Siemens inks agreement with Wyeth...
  • PPD in agreement with i-clinics...

Company Profile: An interview with Arif Khan, president, Clinical Trials Reciprocal Insurance Company (CTRIC)

To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick herefor subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs